drugset

drugset / Trial / NCT00454545

Atorvastatin in Moderate Active Crohns Disease

NCT00454545 ↗

Phase 2 Completed 12 enrolled Skane University Hospital

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Open pilot study to collect information regarding the effect of atorvastatin on patients with active Crohns disease.

Timeline

Start: 2006-10
Primary completion: —
Completion: 2007-10

Publications

Grip O, Janciauskiene S. Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease. PLoS One. 2009;4(5):e5263. doi: 10.1371/journal.pone.0005263. Epub 2009 May 6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atorvastatin	Small molecule	80 mg	—

Indications